The fully integrated research and development operations of Basilea Pharmaceutica Deutschland GmbH are currently focused on antibiotics and antifungals, as well as on the development of dermatology and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options in the hospital and specialty care setting.